EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Serum selenium concentration in patients with ulcerative colitis



Serum selenium concentration in patients with ulcerative colitis



Danish Medical Bulletin 36(6): 568-570



Selenium deficiency may be implicated in the pathogenesis of some human diseases, including colon cancer. The incidence of carcinoma of the colon is increased in patients with ulcerative colitis. We measured the serum concentration of selenium (S-Se) in 20 patients with ulcerative colitis and 20 sex-, age-, height- and weight-matched controls. Although no significant difference was found in mean S-Se between patients and controls (patients: S-Se = 0.93 mumol/l, controls: S-Se = 0.98 mumol/l), the S-Se level decreased with increasing extension of the disease (p less than 0.02). No correlation was found between S-Se and the sex, age, height, or weight of the person or between S-Se and the activity or duration of the disease. The inverse correlation between S-Se and the extension of the disease may be caused by a decreased absorption of selenium from the diseased colon in ulcerative colitis. The significance of the decreased S-Se in patients with extensive disease is unknown, but the possibility exists that this may further increase their risk of developing colonic cancer.

(PDF 0-2 workdays service: $29.90)

Accession: 002219863

Download citation: RISBibTeXText

PMID: 2612226



Related references

Concentration of selenium in serum of patients with ulcerative colitis. Przeglad Lekarski 49(9): 292-293, 1992

Decreased serum concentration of selenium in patients with ulcerative colitis. Scandinavian Journal of Gastroenterology Supplement 23(145): 115, 1988

Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. American Journal of Clinical Nutrition 104(1): 113-120, 2016

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis. Gastroenterology 147(6): 1296-1307.E5, 2015

Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis. International Journal of Clinical Pharmacology and Therapeutics 48(5): 297-308, 2010

Serum concentration of interleukin 10, anti-mannan Candida antibodies and the fungal colonization of the gastrointestinal tract in patients with ulcerative colitis. Advances in Medical Sciences 54(2): 170-176, 2010

Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scandinavian Journal of Gastroenterology 28(7): 605-608, 1993

Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis. Gut 12(4): 297-302, 1971

Ulcerative Colitis and Crohn's Disease Are Associated with Decreased Serum Selenium Concentrations and Increased Cardiovascular Risk. Nutrients 8(12): -, 2016

Serum R-proteins concentration in children with non-specific ulcerative colitis. Pediatriya (Moscow) 0(2): 64-66, 1994

Alpha 1-antitrypsin serum concentration and phenotypes in ulcerative colitis. Digestion 29(2): 124-128, 1984

Serum zinc, selenium and copper concentration in children with allergic colitis. East African Medical Journal 73(4): 236-238, 1996

Use of the microalgae Spirulina platensis and its selenium-containing form in nutrition of patients with nonspecific ulcerative colitis. Voprosy Pitaniia 70(5): 17-21, 2001

Use of the microalgae Spirulina platensis and it's selenium enriched form in nutrition of the patients with unspesific ulcerative colitis. Voprosy Pitaniya 70(5): 17-21, 2001

Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis. European Journal of Clinical Pharmacology 69(3): 431-438, 2013